Course Overview

> The aim of this course is:

- To gain insight into different preference valuation techniques and
(pharmaco) economic evaluation methods.
- To be able to describe the elements and scope of Health Technology
Assessment (HTA).
- To be able to execute a cost study and how to take into account the
perspective in such studies.
- To be able to calculate the different effect measures used in
pharmacoeconomics.
- To be able to describe the different approaches for valuation of
health states and to interpret these values.
- To be able to conduct a pharmacoeconomic analysis including all
relevant aspects (incremental cost-effectiveness ratio (ICER), type of
outcome analysis including differential timing, health outcomes
models, and sensitivity analysis).
- To be able to evaluate the quality of a pharmacoeconomic evaluation
study.
- To be able to design a pharmacoeconomic study(extendeion).

Learning Achievement

Competence

Course prerequisites

- Post-graduated leve in Health or Life Sciences.
- Language prerequisites: Non-native English speakers must provide a
certificate proving a minimum of English B2 level (cf. Europass
[http://europass.cedefop.europa.eu/]).
- Computer and internet requirement.

Grading Philosophy

- Assessment is a mix of continuous assessment.
- Final assessment takes place by videoconference.

Course schedule

> This course consists of the following parts:

- Introduction.
- Costs.
- Effects.
- Pharmacoeconomic analysis.
- How to perform a good pharmacoeconomic evaluation.

Course type

Recorded and live lectures, readings, home assignments, on-line quizzes, forums, wikis, live seminars.

Online Course Requirement

Instructor

Other information

- Professionals: 3,000€/year.
- Students: 1,500€/year.
- No additional costs and no mobility required.

*  This course can be taken in an extended version of 6 months (24
weeks).Duration: 12 weeks * (See below: Other info.)

Language of instruction: English
Mode of delivery: E-learning

Site for Inquiry